Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: MRR

Vaccines Market Size To Reach USD 153.49 Billion, With at a 14.1% CAGR between 2022 to 2028 | Brandessence Market Research

LONDON, Sept. 26, 2023 /PRNewswire/ -- According to a comprehensive research report by Brandessence Market Research (BMRC), "Vaccines Market Size, Share, Companies & Trends Analysis Report By Technology, By Indication, By End User, Based On Region, And Segment Forecasts, 2022-2028". The Vaccines Market was valued at USD 56.98 billion in 2021 and expected to reach USD 153.49 billion By 2028, amplifying with a CAGR of 14.1% over 2022-2028.

Market Overview:

In a world that has been irrevocably altered by the COVID-19 pandemic, the vaccines market has come into sharper focus than ever before. With the race to develop effective vaccines against the virus, the industry has witnessed unprecedented growth and innovation. However, the vaccines industry is not limited to just one virus; it encompasses a wide range of vaccines designed to combat various diseases. In this article, we will delve into the market, exploring its scope, segmentation, market dynamics, and its promising outlook.

Scope of the Vaccines Market:

Report Metric


Vaccines Market Revenue forecast in 2028

USD 153.49 billion

Market Size in 2021

USD 56.98 billion

Market Growth Rate

CAGR of 14.1% from 2022 to 2028

Base Year


Study Period


Key Players/Companies

Glaxo Smith Kline plc, Pfizer Inc., Merck & Co. Inc., Sanofi, CSL Limited, Emergent BioSolutions Inc., Johnson & Johnson, Medimmune LLC, AstellasPharma Inc., Serum Institute of India, Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Company Limited, Panacea Biotech, Protein Sciences Corporation, AstraZeneca, Abbott, Bristol-Myers Squibb, Novavax Inc., Gritstone Oncology, PaxVax Corporation., Bharat Biotech., VBI Vaccines Inc., Dynavax Technologies Corporation, Immunomic Therapeutics Inc., Gamma Vaccines Pty Limited, Sinovac Biotech Ltd., Janssen Pharmaceutical Company, Takeda Pharmaceuticals Company Ltd., Valeant Pharmaceuticals International Inc., China National Biotech, Tiantan, Hualan, Kangtai, Prokarium, ImmunoBiology Ltd.

The scope of the vaccines market is vast, covering a plethora of infectious diseases and preventive measures. Vaccines are biological products that stimulate the immune system to produce an immune response against specific pathogens. This market extends its reach to vaccines targeting diseases such as influenza, hepatitis, polio, measles, mumps, rubella, and more. Additionally, the recent surge in vaccine development for emerging diseases like COVID-19 has showcased the industry's capacity for rapid response.

Moreover, the vaccines market has witnessed an expansion into therapeutic vaccines, which hold the potential to treat diseases like cancer and autoimmune disorders. The market's scope, therefore, is not just limited to prevention but also includes treatment, making it a crucial segment of the pharmaceutical and healthcare sectors.

Get Free Sample PDF Brochure:


Segmentation of the Vaccines Market:

The market can be segmented in various ways to provide a comprehensive view of its dynamics. Here are some key segments:

1. Type of Vaccine:

2. Disease Indication:

3. Age Group:

4. Region:

Browse In-depth Market Research Report (300 Pages) on Vaccines Market:


Competitive Hierarchy:

The prominent players Vaccines Market Outlook are-

Market Dynamics:

1. Growing Awareness and Immunization Campaigns

The global awareness of the importance of vaccination has surged, driven by educational campaigns and increasing access to information. Governments and healthcare organizations worldwide are running immunization programs to reach underserved populations, contributing to market growth.

2. Expanding Investment in Research and Development

The COVID-19 pandemic has highlighted the need for rapid vaccine development. This has led to increased investment in research and development, fostering innovation in vaccine technology.

3. Rising Disease Burden

As global populations grow and age, the burden of infectious and non-infectious diseases is on the rise. This necessitates the development of new and improved vaccines.

4. Regulatory Support and Stringent Quality Control

Governments and regulatory bodies play a pivotal role in ensuring vaccine safety and efficacy. Stringent quality control measures are in place to maintain public trust.

Purchase Copy of This Research Report @:


Vaccines Market Outlook:

The future of the vaccines market is bright. It is expected to continue its growth trajectory due to ongoing research and development efforts, increased disease awareness, and government support. The global vaccine market is also likely to benefit from advancements in vaccine technology, including mRNA vaccines and personalized vaccines tailored to individual genetic profiles.

Additionally, the lessons learned from the rapid development of COVID-19 vaccines have paved the way for a more agile and responsive industry, better prepared to tackle emerging threats. With a broader range of preventive and therapeutic vaccines on the horizon, the market is poised to play a pivotal role in shaping the future of healthcare.


The vaccines market is not just about preventing diseases; it is about safeguarding public health and driving innovation in healthcare. As we navigate the challenges of an ever-evolving healthcare landscape, the vaccines market will remain at the forefront, offering hope, protection, and a brighter future for humanity.

Related Reports:

Demodex Blepharitis: How to Achieve Eye Health and Eliminate Demodex

Navigating Solid Tumor Diseases: Insights and Consulting Services

Unveiling Hope: Navigating Duchenne Muscular Dystrophy (DMD)

Unlocking Relief: Effective Psoriasis Disease Management Strategies

Unlocking the Latest Breakthroughs in Alzheimer's Disease Research: Hope on the Horizon

Rising Against the Odds: Global Insights into Multiple System Atrophy (MSA) Disease

Case study on the Development of Innovative Medicine

Case Study: Software Application for Personalized Care with Data-Driven Insights

Case Study: Cancer Vaccine with Specific Antigens

Combination Trials for Lung Cancer Immunotherapy - Case Study

Using software to manage the supply chain and the inventory

Asset Scouting for Cystic Fibrosis: A Case Study

A Revolutionary Non-Invasive Glucose Monitoring Device Receives Regulatory Approval and Effective Commercialization

Investment in Pancreatic Cancer Chemotherapy

Predictive Analytics Powered by AI: Unlocking Insights for the Future of Healthcare

Natural Language Processing (NLP) in Healthcare: Unlocking the Potential

Posluma: A Targeted Oncology Breakthrough in Prostate Cancer Imaging

Fezolinetant by Veozah: Advancing Women's Health by Astellas Pharma Inc.

A Hopeful Sign for Migraine Sufferers: Zavzpret

Rethinking Treatment Options for a Better Future with Hemophilia Gene Therapy

About Us:

Brandessence Market Research & Consulting Pvt ltd.

Brandessence Market Research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in?Pune, India?and our sales office is in?London.

Follow Us:?LinkedIn ?


Mr.?Vishal Sawant?
Email:[email protected]
Email:[email protected] 
Corporate Sales:?+44-2038074155?
Asia Office:?+917447409162

Logo: https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg

SOURCE Brandessence Market Research And Consulting Private Limited

These press releases may also interest you

at 01:21
Hansa Biopharma, "Hansa" , today announced positive high-level data from the 15-HMedIdeS-09 phase 2 trial that demonstrated imlifidase was safe and well tolerated when administered prior to standard of care, including rapid improvement in...

at 01:00
Global Identity Verification and Digital KYC solutions provider, Accura Scan is pleased to announce being awarded ISO/IEC 30107-03 compliance after passing a presentation attack detection (PAD) iBeta Level 2 audit with 0% FAR, making it one of the...

at 00:00
FireflySci, a pioneering leader in spectroscopy cuvette and calibration standards, proudly announces its unique position as the only custom cuvette manufacturer located in the United States. This...

6 déc 2023
The Milken Institute's fifth annual Middle East and Africa (MEA) Summit will take place December 7-8, 2023 at the Rosewood Hotel Abu Dhabi. This year's theme is "Navigating Complexity through Collaboration," highlighting the importance of business...

6 déc 2023
The acrolein market is expected to grow by USD 229.77 million from 2023 to 2028. In addition, the growth momentum of the market will progress at a CAGR of 3.71% during the forecast period, according to Technavio. Growing plastic and polymer...

6 déc 2023
The bioreactors market is expected to grow by USD 2.23 billion from 2023 to 2028. In addition, the momentum of the market will progress at a CAGR of 6.99% during the forecast period, according to Technavio Research. The market has been segmented by...

News published on and distributed by: